[ad_1] According to the neurologist, a positive therapy study of progressive forms of MS at the secondary-chronic stage is also interesting. "The siponimod modulator S1P slowed the progression of these in a …
Read More »[ad_1] According to the neurologist, a positive therapy study of progressive forms of MS at the secondary-chronic stage is also interesting. "The siponimod modulator S1P slowed the progression of these in a …
Read More »